Alfa Romeo’s famous crest has received a redesign ahead of its 115th year starting 24 June 2025, with the Biscione snake now ...

Guggenheim analyst Vamil Divan maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...

A new ad from the Coca-Cola Co. opens with a shot of a typewriter clacking out Stephen King’s The Shining. The viewer follows ...

Walter Käch's 'Lettering' is cult classic design book whose ripple effects can be seen in some of the biggest brands of today ...

Taking to Instagram, Lin shared the designs with Hamilton fans, explaining that he was tasked with the tricky challenge of ...

Ask a group of theatre fans what the most iconic musical logo is and one name in particular is likely to crop up – Hamilton.

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

Merck is forking out $5.85 per share for the California company, a sizeable premium on Immune Design’s share price of around $1.50 in the weeks building up to the deal, and which values it at ...

RIT offers undergraduate and graduate degree programs that prepare you for professional work in research laboratories and industrial settings. The materials science graduate program seeks to provide ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

Merck licenses the protein, called berahyaluronidase alfa, from Alteogen. Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents.

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...